It has been reported that a higher Ki67 value using the hotspot is strongly correlated with poor outcome and the determination of proliferation markers in BC should be standardised to hotspot counting, as it showed greater risk of shorter tumour‐free survival.15, 32. Here, MKI67 is linked to breast cancer.